-- 義法半導體(STMicroelectronics,股票代號:STMPA.PA,STMMI.MI)第一季營收年增23%,主要得益於其2月完成的恩智浦半導體(NXP Semiconductors,股票代號:VNX.F)微機電系統(MEMS)感測器業務的收購。 截至週四下午早些時候,該公司股價在米蘭和巴黎均上漲7%。 這家半導體製造商截至3月28日的三個月內,以美國通用會計準則(US GAAP)計算的淨營收從去年同期的25.2億美元增至31億美元,其中包括MEMS感測器業務貢獻的4,000萬美元營收。剔除此項貢獻後,淨營收年增21.4%。 同期毛利也從8.41億美元增加至10.5億美元,其中已計入收購產生的1,100萬美元購買價格分配影響。毛利率為33.8%,上升40個基點。 營業收入從300萬美元飆升至7,000萬美元,其中包括本季7,100萬美元的減損損失、重組費用和其他相關淘汰成本。另一方面,歸屬於母公司股東的淨利從5,600萬美元降至3,700萬美元。所有指標均採用美國通用會計準則(US GAAP)。 「第一季淨收入(不包括收購恩智浦半導體MEMS感測器業務的貢獻)高於我們業務預期範圍的中值,這主要得益於我們在個人電子產品和CECP(消費電子、電氣、通信和產品)領域的客戶項目收入增長。毛利率高於我們業務預期範圍的中值,主要歸功於產品組合的優化,」總裁兼總裁Jean-Marc Chery總裁表示。 意法半導體第二季業務預期中位數為淨收入達34.5億美元,較去年同期成長24.9%。展望未來,該公司確認其資料中心營收預期在2026年將「遠超」5億美元,並在2027年遠超10億美元,這主要得益於人工智慧驅動型新項目帶來的預期成長。 AlphaValue/Baader Europe的分析師在一份報告中指出:「需求指標正在改善,人工智慧相關營收的可見性正在迅速提升,庫存正常化也消除了主要的周期性不利因素。該公司在人工智慧基礎設施、汽車電氣化、工業自動化和矽光子學領域的佈局創造了多重結構性成長動力,支撐了管理層對2026年兩位數營收成長的預期。” 這項展望出台之際,該公司預計未來幾季人工智慧業務將保持「強勁」成長動能。在媒體電話會議上,當被問及與人工智慧相關的投資計畫或潛在收購時,奇瑞表示,該公司不時會進行一些小規模收購,但目前沒有在該領域進行任何重大交易的計畫。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.